F,N-Doped carbon dots as efficient Type I photosensitizers for photodynamic therapy.
Xiaoyan WuMingsheng XuShuna WangKhurram AbbasXin HuangRenquan ZhangAntônio Cláudio TedescoHong BiPublished in: Dalton transactions (Cambridge, England : 2003) (2022)
Photodynamic therapy (PDT) is a promising and emerging method for the treatment of cancer. Usually, Type II PDT is used in the clinic, and mainly involves three key elements: a photosensitizer, molecular oxygen and laser light. However, it is known that tumor tissue is deficient in oxygen molecules which is why Type I PDT is mostly preferred in the therapy of tumors in which the hypoxic tissue plays a major role. Fluorescent carbon dots (CDs) have shown great potential in cancer theranostics, acting as bioimaging agents and photosensitizers. Herein, we have synthesized novel kinds of fluorine and nitrogen co-doped carbon dots (F,NCDs) that emit bright green fluorescence under ultra-violet light. The F,NCDs have excellent water solubility and low cytotoxicity. They can generate hydroxyl radicals (˙OH) and superoxide anions (˙O 2 - ) under LED light (400-500 nm, 15 mW cm -2 ) irradiation, making them ideal photosensitizers for Type I PDT. Furthermore, upon using the HepG2 cell line as an in vitro model, the F,NCDs exhibit a better cell imaging effect and higher PDT efficiency than the control sample of CDs without F and N doping. This work has illustrated that the F,NCDs are promising in achieving the image-guided PDT of cancers, usually in a hypoxia tumor microenvironment.
Keyphrases
- photodynamic therapy
- quantum dots
- fluorescence imaging
- papillary thyroid
- energy transfer
- high resolution
- squamous cell
- primary care
- single cell
- single molecule
- cell therapy
- hydrogen peroxide
- mesenchymal stem cells
- living cells
- risk assessment
- nitric oxide
- bone marrow
- radiation therapy
- young adults
- high speed
- human health
- replacement therapy
- amino acid
- combination therapy
- fluorescent probe
- transition metal